2007
DOI: 10.1016/j.puhe.2006.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Status of forest onchocerciasis in the Lower Cross River Basin, Nigeria: Change in clinical and parasitological indices after 6 years of ivermectin intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
7
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 6 publications
2
7
1
Order By: Relevance
“…The differences among the villages could be due to differences in their therapeutic coverage and compliance rate. This decrement in prevalence of the microfilaria was in agreement with a study conducted in the lower cross river basin of Nigeria [ 12 ], which had nearly a comparable therapeutic coverage with the current study area, had annual treatment schedule and also conducted after six years of intervention. Similar effects were also observed in Yanomami communities in the Brazilian Amazon [ 13 ], and other studies [ 14 ], [ 15 ] and [ 16 ].…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…The differences among the villages could be due to differences in their therapeutic coverage and compliance rate. This decrement in prevalence of the microfilaria was in agreement with a study conducted in the lower cross river basin of Nigeria [ 12 ], which had nearly a comparable therapeutic coverage with the current study area, had annual treatment schedule and also conducted after six years of intervention. Similar effects were also observed in Yanomami communities in the Brazilian Amazon [ 13 ], and other studies [ 14 ], [ 15 ] and [ 16 ].…”
Section: Discussionsupporting
confidence: 91%
“…Therefore a reduction in prevalence was expected. So, a study conducted in Nigeria[ 12 ] was considered for the assumption because, one, the prevalence at the baseline was 74% which was comparable to the prevalence in the study area at the baseline, second, the study was conducted after six years of the intervention again which was similar to the current study and the therapeutic coverage was almost comparable with the current study area, therefore like this study a 35.9% reduction from the pre intervention prevalence was assumed Threfore, P for this study was 48% (0.48).…”
Section: Methodsmentioning
confidence: 99%
“…Another crucial factor could be lack of close monitoring of drug treatment and distribution by community -directed distributors (CDD) often occasioned by technical and logistic limitations in their ability to deliver interventions [1,2,5,18]. It has been equally suggested that poor compliance to treatment may not be unrelated to long treatment duration (10 -15 years), interval between doses (one year) that can easily be forgotten and thus missed, adverse events in ivermectin treatment often leading to rejection of treatments by communities [1, 3,6]. Reinvasion caused by limited treatment coverage area has also been implicated in low CDTI programme success [15,17,19].…”
Section: Communitymentioning
confidence: 99%
“…Other factors reported by respondents include dislike for the drugs (3.4%) and fear of ivermectin-related adverse reactions (9.3%) were in agreement with [15,16] that reported fear of adverse reaction as reason for noncompliance with intake of the drugs. Adverse events in ivermectin treatment have also been acknowledged to lead to rejection of treatments by communities [1, 3,6]. Thus this could limit treatment coverage and impact on possible reinvasion and perpetuate onchocerciasis endemic status of the study community.…”
Section: Major Themementioning
confidence: 99%
See 1 more Smart Citation